百济神州（ONC）今日盘前股价大跌5.20%，引起了市场的广泛关注。
消息面上，此次下跌与港股创新药板块整体大幅回调有关，百济神州在板块中领跌。尽管公司此前发布了强劲的2025年业绩，但部分资金选择“利好出尽”式撤离，这是A股和港股市场常见的博弈行为。同时，市场对创新药企的定价逻辑正在发生根本性转变，从单纯看重管线储备转向研发能力、商业化能力与合规能力的综合考量。
百济神州2025年业绩显示，公司实现营业总收入同比增长40.4%，并成功扭亏为盈。然而，在财报公布后，市场资金流向的变化和板块情绪的调整，共同导致了股价的短期承压。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.